19520: Case studies

An image of a gloved hand holding a dropper tool dropping fluid in a test tray

Biotech

Explore key learnings from our strategic collaboration with leading pharma companies to develop targeted solutions.

Pharma case studies

Explore Biotech

Our biotechnology consulting team brings strategic insights that help biotech companies build value and innovate with confidence.

A close up shot of capsule pills on an assembly line

Explore Pharma

From pharmaceutical M&A to capital optimization and more, we empower the pharmaceutical industry to drive innovation and growth.

Pharma

An image of an opening of a medical scanning device

Explore MedTech

We work closely with leading and emerging companies across the medical technology industry in key areas such as M&A and supply chain.

MedTech

Real life stories

Industry insights

Where to find us

Key contact

Accelerated access to novel cancer therapies at Moores Cancer Center

How a B2B company drove engagement by transforming its D2C platform

How tech and trust transformed a tax operating model

Global pharmaceutical player Boehringer Ingelheim is reimagining its tax operating model to boost quality and efficiency.

Merck Animal Health modernized its HomeAgain e-commerce site to offer customers a robust online experience that drives growth and expansion.

Moores Cancer Center accelerated activation of high-priority clinical trials by leveraging the EY Clinical Trial Fast Lane solution.

A scientist looking in a microscope in a lab

A woman and her pug dog working on the computer at home

An image of a doctor reviewing results with a female patient in an exam room

Takeda Business Solutions fast-tracked its digitalization evolution through an innovative top-down and bottom-up journey.

What going digital means for Takeda

A scientist peering through the binoculars of a scientific microscope

RTR has significant potential, but pharmaceutical manufacturers looking to adopt it must first meet several prerequisites.

How real-time release (RTR) can transform pharmaceutical manufacturing

An image of a pharmaceutical production line with a robotic arm filling vials

For the pharmaceutical industry, AI can be a powerful tool to drive better-informed asset portfolio decisions.

How AI can support decision-making in drug development portfolios

An image of a female scientist wearing goggles, a lab coat and blue latex gloves working in a lab

Facing a challenging commercial environment, biopharma companies need to embrace an end-to-end, AI-driven strategy to succeed.

How biopharma can get the right mix of people and tech for launch success

An image looking from the back of a young boy playing with a toy airplane during sunset

Discover key insights and unique perspectives on leading solutions and top pharma industry trends.

Pharma thought leadership

Learn more

Life Sciences Future

Watch for us in market at key industry events or join the conversation via our webcast platform as EY thought leaders share new insights on the latest pharma trends.

Pharma events and webcasts

9/25/25

King of Prussia, PA

Learn more

Orlando, FL

February 2-5, 2026

SCOPE Summit 2026

Pharma contact

Arda Ural, PhDEY Americas Life Sciences Sector LeaderErnst & Young LLP

A portrait of Arda Ural, EY Americas Life Sciences Sector Leader Ernst & Young LLP

As pharma supply chains evolve in a disrupted global operating environment, the limitations of existing supply chains are increasingly evident.

What pharma supply chain transformation means for tax

An image of a chemist analyzing samples in a modern lab

The use of GenAI in drug discovery is increasing across pharma, with potential benefits including enhanced speed and cost savings.

How pharma can benefit from using GenAI in drug discovery

Scientists working on computer developing drugs in a lab

Life sciences dealmaking volume is stable, but value is down – how will smaller, smarter deals unlock a more confident future?

EY Firepower report: life sciences dealmaking – trends in 2025

A close up shot of two children playing chess together

When patent expiration looms, strategic planning across functions can help pharma leaders increase value.

Drive commercial success by effectively navigating loss of exclusivity

An image of a pharmaceutical assembly line filling in glass bottles with red tablet pills

Pharmacies, benefit managers and carriers are looking for opportunities to create value and differentiate.

Disruptions to the pharmacy and PBM value chain

A close up image of a person's hands holding a pill bottle and reading the label

It is critical for life sciences leaders to differentiate their products’ clinical and economic value to drive both access and commercial success.

Integrated evidence planning and generation as a differentiator

An image of a researcher wearing a virtual reality headset and a face mask working

As the industry continues to evolve, pharma manufacturing leaders need to leverage a new approach to performance improvement.

How digital helps pharma manufacturers drive operational excellence

An automated assembly line for organizing bottles of drugs

Arda Ural, PhDEY Americas Life Sciences Sector LeaderErnst & Young LLP

Biotech contact

Boston, MA

May 19-21, 2026

Bio-IT World Expo

Learn more

La Jolla, CA

February 24, 2026

Biocom Global LS Partnering Conference

Learn more

Orlando, FL

February 2-5, 2026

SCOPE Summit 2026

Watch for us in market at key industry events or join the conversation via our webcast platform as EY thought leaders share new insights on the latest biotechnology trends.

Biotech events and webcasts

Innovation has been the lifeblood of human productivity and value creation since the Industrial Revolution.

Innovation is moving at an unprecedented speed. Are you staying with it?

Image created by EY's proprietary LLM following the prompt; disruptive innovation and futuristic biotechnology

2024 IPOs outpace the last two years by volume and value.

Biotech IPOs get a bump in Q3

An image of a businesswoman giving a presentation using visual aids behind her

Texas stands ready to capitalize on the opportunities that recovery across the biotech ecosystem may bring.

Beyond Borders - Texas Edition

A shot from the sky overlooking the Margaret Hunt Hill bridge and downtown Dallas, USA

As biopharma companies look to new markets for growth, leaders need to tailor their expansion efforts to the nuances of each market.

Key steps for improving biopharma expansion into new markets

A close up shot of a chemist wearing blue latex gloves and a white lab coat working in a laboratory

As biopharma companies face a rapidly changing political landscape, we explore industry performance over the last year, including strategies that will position companies for long-term success.

EY Biotech Beyond Borders Report 2025

Female neuroscientist using interactive touch screen table

Discover key insights and unique perspectives on leading solutions, top biotech trends and industry-transforming issues.

Biotech thought leadership

EY teams helped the biopharma company solve operational and financial challenges, helping it to focus on groundbreaking drug research.

How IntraBio's finance transformation fueled its global expansion

Close up of a scientist's hands pipetting a sample into a multi well plate for dna analysis

Strategy in Action, a CEO series by EY-Parthenon.

CEO of Bayer AG on mission-first strategy

The pharmaceutical company sought to improve site relationships and drive industry-leading practices.

Bayer's journey to becoming a preferred partner in clinical trials

A patient being pushed by a nurse in a wheelchair talking to a doctor in a hospital hallway

Explore key learnings from our strategic collaboration with leading biotech companies to develop targeted solutions.

Biotech case studies

Key contact

Where to find us

Industry insights

Real life stories

John BabittEY Global MedTech Leader Ernst & Young LLP

MedTech contact

Learn more

Dana Point, CA

March 16-20, 2026

LSI USA '26 Emerging MedTech Summit

Watch for us in market at key industry events or join the conversation via our webcast platform as EY thought leaders share new insights on the latest MedTech industry trends.

MedTech events and webcasts

Discussion with executive leaders from top Life Sciences companies.

Pursuing the right deals now to deliver value into the future

A close-up image of a person using a template to analyze data

Industry players walk a narrow path between converging topline and bottom-line pressures.

MedTech continues to drive innovation amid ongoing industry challenges

A close-up image of a hand holding a microchip with a two prong instrument

Reigniting growth and expanding markets.

Pulse of the MedTech Industry Report 2025

An image of a scientist wearing a lab coat and goggles interacting with a virtual reality model of a human skeleton

Discover key insights and unique perspectives on leading solutions and top MedTech industry trends.

MedTech thought leadership

A supply chain transformation enabled more personalized care for over 78 million patients.

How Medtronic’s optimized supply chain gets products to patients in need

Medics and patient in during an oncology treatment

Hear from John Babitt, EY Global MedTech Leader, as he shares important highlights on the state of the industry.

The state of MedTech 2025

Explore key learnings from our strategic collaboration with leading MedTech companies to develop targeted solutions.

MedTech case studies

Key contact

Where to find us

Industry insights

Real life stories

Learn more

Bridgewater, NJ

October 30, 2025

Bio NJ C-Suite Summit

Learn more

Philadelphia, PA

March 16-17, 2026

Reuters Pharma USA

Real life stories

Industry insights

Learn more

Key contact

Where to find us

Industry insights

Real life stories

Key contact

Where to find us

Industry insights

Real life stories

Key contact

Where to find us

Industry insights

Real life stories

Key contact

Where to find us

Industry insights

Real life stories

Learn more

GenAI has helped organize the agronomic knowledge in a way that makes retrieval easy and accessible.

Large language models are planting the seeds of the future

AI plant experts reviewing data in a cornfield

Strategy in Action, a CEO series by EY-Parthenon.

CEO of Bayer AG on mission-first strategy

EY solutions helped transform and improve its clinical site invoicing and payment approach.

Leading pharma company sought to improve site relationships and drive leading practices

A nurse pushing patient in wheelchair talking to a doctor in a hospital hallway

EY solutions helped transform and improve its clinical site invoicing and payment approach.

Leading pharma company sought to improve site relationships and drive leading practices

Learn more

San Diego, CA

10/5/25

2025 AdvaMed MedTech Conference

Learn more

Monarch Beach, CA

3/16/25

2025 LSI Conference: MedTech 2025 - Here Come the Deals

Learn more

New York, NY

10/22/25

15th Annual AVBCC Summit

Learn more

King of Prussia, PA

9/25/25

Life Sciences Future

Learn more

Philadelphia, PA

3/23/25

Life Sciences Accounting & Reporting Congress by Informa

Our deep experience helped a pharma company establish a global footprint.

How confident are you turning your vision into value?

A scientist in a face mask taking notes while conducting a test in a medical laboratory

Takeda Business Solutions fast-tracked its digitalization evolution through an innovative top-down and bottom-up journey.

What going digital means for Takeda

As the industry continues to evolve, pharma manufacturing leaders need to leverage a new approach to performance improvement.

How digital helps pharma manufacturers drive operational excellence

Learn more about how EY teams can help you respond to changes that you can’t afford to ignore.

How to make account-based selling work for pharma

Image of a female medical sales representative speaking with a medical professional in a lab coat.

Discussion with executive leaders from top Life Sciences companies.

Pursuing the right deals now to deliver value into the future

Industry players walk a narrow path between converging topline and bottom-line pressures.

MedTech continues to drive innovation amid ongoing industry challenges

For top performers, R&D investments fuel growth, increase investor confidence and unlock total shareholder return.

Investing in innovation: unlocking value in MedTech

An image of a female doctor wearing gloves while analyzing a mold on a computer screen

Discussion with executive leaders from top Life Sciences companies.

Pursuing the right deals now to deliver value into the future

The “golden batch” approach is poised to revolutionize pharma manufacturing by setting the standard for an ideal production run.

How to reach gold-standard operations in pharmaceutical manufacturing

An image of three medical professionals inside a darkly lit laboratory surrounded by multiple types of medical devices

Facing a challenging commercial environment, biopharma companies need to embrace an end-to-end, AI-driven strategy to succeed.

How biopharma can get the right mix of people and tech for launch success

Discover how EY teams helped Sigma simplify and standardize to boost availability and cut inventory by 20%.

How Sigma, an Australian pharmaceutical company, transformed its supply chain

An image of a pharmacist examining a machine in a room surrounded by shelves full of medicines.

Moores Cancer Center accelerated activation of high-priority clinical trials by leveraging the EY Clinical Trial Fast Lane solution.

Accelerated access to novel cancer therapies at Moores Cancer Center

Texas remains a compelling microcosm within the global biotech sector, which is marked by both uncertainty and promise.

EY Biotech Beyond Borders Report 2025: Texas Edition

An EY-Parthenon team helped BMS establish a cash leadership office as part of an award-winning Treasury transformation. Learn more in this case study.

How Bristol Myers Squibb overhauled working capital to fund its future

An image of two colleagues working together in a conference room in a modern workplace setting.

Discover how EY teams helped Sigma simplify and standardize to boost availability and cut inventory by 20%.

How Sigma, an Australian pharmaceutical company, transformed its supply chain

As the industry continues to evolve, pharma manufacturing leaders need to leverage a new approach to performance improvement.

How digital helps pharma manufacturers drive operational excellence

GenAI and related tools can help improve the design of clinical trials and speed data gathering and regulatory reporting.

When and how to use GenAI in late-stage clinical development

Image of a futuristic medical lab with AI powered equipment

Learn more about how EY teams can help you respond to changes that you can’t afford to ignore.

How to make account-based selling work for pharma

An image of a female pharmaceutical sales rep shaking hands and speaking with a medical professional in a lab coat outside of a medicla facility.

Facing intensifying pressure to drive stronger customer engagement, growth and efficiency, organizations in the industry must evolve.

How to accelerate growth through commercial transformation in pharma

Image of two scientists in a lab reviewing samples at a microscope

GenAI and related tools can help improve the design of clinical trials and speed data gathering and regulatory reporting.

When and how to use GenAI in late-stage clinical development

The number of biotech raises from VC has gone down, while the average size of investment has gone up.

Biotech venture capital returns, reimagined

A graphic of a combination bar and line chart

Venture capital (VC) investment continues to evolve across both value and volume.

Venture Capitalists remain highly selective

Learn more

Early- and mid-stage deals will dominate the second half of the year

Robust first half of 2024 for life sciences dealmaking

Image looking up towards tall high-rise buildings on a cloudy day

Facing intensifying pressure to drive stronger customer engagement, growth and efficiency, organizations in the industry must evolve.

How to accelerate growth through commercial transformation in pharma

Innovation has been the lifeblood of human productivity and value creation since the Industrial Revolution.

Innovation is moving at an unprecedented speed. Are you staying with it?

CRM must evolve from analogue maps to real-time GPS for pharma. Unlock deeper insights — transform your customer engagement now.

How next-generation CRM will reshape the life sciences commercial model

Image of doctor having an online appointment virtual call with patients

Early- and mid-stage deals will dominate the second half of the year

Robust first half of 2024 for life sciences dealmaking

As biopharma companies face a rapidly changing political landscape, we explore industry performance over the last year, including strategies that will position companies for long-term success.

EY Biotech Beyond Borders Report 2025

Innovation has been the lifeblood of human productivity and value creation since the Industrial Revolution.

Innovation is moving at an unprecedented speed. Are you staying with it?

As the need for enhanced traceability intensifies, modern solutions can help organizations drive patient safety and product integrity.

How to enhance traceability in the life sciences supply chain

Assembly line in factory glass vials being filled with pills and tablets

CRM must evolve from analogue maps to real-time GPS for pharma. Unlock deeper insights — transform your customer engagement now.

How next-generation CRM will reshape the life sciences commercial model